STEVE PAKOLA
CIK 1700659 · Chief Medical Officer · last filed 2026-05-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.55M
Companies
2
Total Filings
17
Lifetime Open-Market Net
-$1.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Medical Officer | 232,617 | $6.66 | $1.55M | -$1.01M | 15 | 2026-05-13 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Chief Medical Officer | — | $33.00 | — | $0 | 1 | 2019-02-20 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-05 | RGNX | Mixed | +85,613 | -$111.2K | EDGAR |
| 2022-01-04 | RGNX | Mixed | +6,150 | -$91.6K | EDGAR |
| 2021-01-06 | RGNX | Grant (A) | +11,000 | $0 | EDGAR |
| 2020-01-06 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2019-04-19 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2019-02-20 | Whitehawk Therapeutics, Inc. (ARPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-25 | — | Grant (A) | — | $0 |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.